76 studies found for:    "Patent ductus arteriosus"
Show Display Options
Rank Status Study
21 Terminated
Has Results
Early Versus Late Use of Ibuprofen for Patent Ductus Arteriosus (PDA) Closure
Conditions: Patent Ductus Arteriosus;   Prematurity
Intervention: Drug: Ibuprofen
22 Completed Oral Paracetamol Versus Oral Ibuprofen in Management of Patent Ductus Arteriosus in Preterm Infants: A Randomised Controlled Trial
Condition: Patent Ductus Arteriosus
Interventions: Drug: Oral paracetamol;   Drug: Oral ibuprofen
23 Completed Do Elevated BNP Levels Predict Hemodynamically Significant PDAs
Condition: Patent Ductus Arteriosus
Intervention:
24 Unknown  Serum Level Measurement of Oral Paracetamol and Oral Ibuprofen for Patent Ductus Arteriosus Treatment in Preterm Infants
Condition: Patent Ductus Arteriosus
Interventions: Drug: Oral paracetamol;   Drug: Oral ibuprofen
25 Completed Ibuprofen vs. Continuous Indomethacin in the Treatment of PDA
Condition: Patent Ductus Arteriosus
Interventions: Drug: Continuous indomethacin;   Drug: ibuprofen
26 Withdrawn Brain, Gut and Kidney Blood Flow During Medical Closure of PDA
Condition: Patent Ductus Arteriosus
Intervention: Device: INVOS Cerebral/Somatic oximeter
27 Not yet recruiting Early Treatment Versus Expectative Management of PDA in Preterm Infants
Condition: Patent Ductus Arteriosus
Interventions: Drug: Ibuprofen;   Other: Expectative Management;   Drug: Indomethacin
28 Recruiting Paracetamol in Patent Ductus Arteriosus
Condition: Ductus Arteriosus, Patent
Interventions: Drug: Paracetamol;   Drug: Ibuprofen
29 Completed Patent Ductus Arteriosus (PDA) Screening Trial
Condition: Ductus Arteriosus, Patent
Interventions: Other: Nondisclosure of screening echocardiogram results;   Other: Disclosure of screening echocardiogram results
30 Withdrawn Second Course of Therapy for Resistant Patent Ductus Arteriosus (PDA)
Condition: Patent Ductus Arteriosus
Interventions: Drug: Indomethacin;   Drug: Ibuprofen
31 Completed Plasma N-terminal proBNP Concentrations and Patent Ductus Arteriosus in Preterm Babies
Condition: Ductus Arteriosus, Patent
Intervention:
32 Recruiting PDA Post NICU Discharge
Condition: Patent Ductus Arteriosus
Intervention:
33 Recruiting Analysis of the Impact of Patent Ductus Arteriosus on Brain Function in Preterm Neonates: Multimodal Approach Integrating EEG-NIRS, Ultrasound and Clinical Data
Condition: Ductus Arteriosus, Patent
Interventions: Device: TFU-NIRS;   Device: NIRS;   Device: EEG
34 Completed
Has Results
Pocket Echocardiography System (PES) for Detection of PDA in Neonates
Condition: Patent Ductus Arteriosus
Intervention: Device: PES first, then FFES
35 Active, not recruiting Paracetamol Treatment of the Borderline Significant PDA
Condition: Patent Ductus Arteriosus
Interventions: Drug: Paracetamol drops;   Other: Placebo
36 Terminated Safety/Efficacy Study of Optimizing Ibuprofen Dosing to Achieve Higher PDA Closure Rates
Condition: Patent Ductus Arteriosus
Interventions: Drug: optimized ibuprofen;   Drug: Standard Ibuprofen
37 Completed Safety and Efficacy Study of Ibuprofen l-Lysine Solution in Premature Infants for Treatment of PDA
Condition: Patent Ductus Arteriosus
Intervention: Drug: ibuprofen l-lysine iv solution (NeoProfen (R) )
38 Completed Feeding During Ibuprofen or Indomethacin Treatment of Preterm Infants
Condition: Patent Ductus Arteriosus
Interventions: Other: feeding;   Other: fasting
39 Completed The Use of B-Type Natriuretic Peptide (BNP) to Predict Closure of a Patent Ductus Arteriosus (PDA) in Premature Infants
Conditions: Indomethacin Therapy;   Patent Ductus Arteriosus
Intervention: Procedure: Withhold standard INDO dose if BNP < 100 pg/ml
40 Recruiting The Best Treatment Strategy: Surgical vs Pharmacological to Close the Ductus Arteriosus Persistent in Preterm Infants
Condition: Persistent Ductus Arteriosus
Interventions: Procedure: Surgical treatment;   Drug: Control group

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.